University of Lethbridge and University of Calgary researchers explore avenues for novel treatments of Hepatitis B Virus HBV is one of the leading causes of liver diseases and cancer
Vaccines bring hope to a pandemic-stricken world With many vaccines in different stages of development, the possibility of stopping the COVID-19 pandemic comes ever nearer
Canada Foundation for Innovation funding will help U of L researchers pursue a drug treatment for COVID-19 Funding helps secure needed infrastructure for Drs. Trushar Patel and Borries Demeler to pursue their search for a COVID drug treatment
U of L forges partnership with the South Alberta Light Horse reserve unit A recent training exercise highlighted opportunities for collaboration
University of Lethbridge – API partnership receives substantial grant from MITACS to develop COVID-19 treatment Scientists from the U of L and API are collaborating to develop a new drug treatment for COVID-19
Grant to enable purchase of state-of-the-art biophysical research equipment The new suite of equipment will help researchers understand key communication events in biomolecules
U of L students form first international chapter of the Biophysical Society New chapter, the first in Western Canada, unites students from the University of Montana and the U of L
Alberta Innovates grant facilitates joint research project on the hepatitis B virus HBV is a global public health problem responsible for a million deaths every year
U of L iGEM teams tackling relevant issues, awarded gold and silver at Giant Jamboree The University of Lethbridge’s iGEM students have proven once again they are among the best and brightest scientists in the synthetic biology field
Research collaboration between University of Lethbridge and University of Calgary takes aim at hepatitis C virus Supported by a CanHepC Network Post-doctoral Fellowship, Meier-Stephenson is utilizing the laboratory expertise of the U of L’s Dr. Trushar Patel in collaboration with UCalgary’s Dr. Carla Coffin